76 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 76 of 76 clinical reviews.
A detailed guide to Aetna (CVS Health) coverage for Zetia (ezetimibe): formulary tiers, prior authorization criteria, step-therapy requirements, appeal rights, and how to cut your out-of-pocket cost to near zero.
A guide to Anthem's formulary coverage, prior authorization criteria, step therapy requirements, and appeal strategies for Zetia (ezetimibe) in 2025.
A guide to Cigna coverage for Zetia (ezetimibe): formulary tiers, prior-authorization criteria, step-therapy requirements, how to appeal a denial, and lower-cost alternatives.
Kaiser Permanente's closed formulary makes Zetia coverage complex. Learn about prior authorization, step therapy, appeal options, and how to get ezetimibe covered or affordable through Kaiser.
Find out whether Medicare Advantage plans cover Zetia (ezetimibe), what formulary tier to expect, prior authorization requirements, step therapy rules, and how to appeal a denial.
State Medicaid coverage for Zetia (ezetimibe) varies widely. Learn which states cover it, how prior authorization works, step-therapy requirements, appeal rights, and what to do if your claim is denied.
A complete guide to TRICARE coverage of Zetia (ezetimibe): formulary tier, prior-authorization criteria, step-therapy requirements, appeal steps, and cost-saving options for military beneficiaries.
UnitedHealthcare typically covers generic ezetimibe at Tier 1-2 and brand Zetia at Tier 3 with prior authorization. Learn formulary placement, step therapy rules, PA criteria, appeal steps, and cost-saving strategies.
MD-level guide to every clinically significant ezetimibe drug-drug interaction, including statins, fibrates, cyclosporine, bile acid sequestrants, and anticoagulants, with PubMed-cited evidence.
Evidence-based guide to ezetimibe (Zetia) 10 mg dosing in adults aged 50-64, covering IMPROVE-IT trial data, polypharmacy considerations, statin combination therapy, and monitoring protocols.
Complete clinical guide to ezetimibe (Zetia) dosing for young adults aged 18-29, including standard dose, timing, combination therapy, fertility considerations, and IMPROVE-IT trial evidence.
Clinical guide to ezetimibe (Zetia) dosing in patients with renal impairment, including pharmacokinetic data, FDA labeling, guideline recommendations, and monitoring considerations.
Is ezetimibe (Zetia) safe during pregnancy or breastfeeding? Review of FDA labeling, animal reproductive data, human case reports, and clinical alternatives for managing hyperlipidemia in pregnant or nursing patients.
A clinical review of ezetimibe's development pipeline, including fixed-dose combinations, novel cholesterol-absorption inhibitors, next-generation NPC1L1 targets, and emerging lipid-lowering strategies beyond statins.
Ezetimibe (Zetia) is an oral tablet, not an injection. Learn how this cholesterol-lowering drug works, its dosing, the IMPROVE-IT trial results, and how it compares to injectable lipid therapies like PCSK9 inhibitors.
Monitoring guide for young adults aged 18 to 29 taking ezetimibe (Zetia). Covers baseline labs, follow-up lipid panels, liver function tests, fertility considerations, and when to contact your prescriber.
A physician-level review of ezetimibe off-label uses beyond FDA-approved hyperlipidemia, with named trials, evidence grades, and clinical guidance for each indication.
A physician-level review of ezetimibe (Zetia) regulatory approvals across major markets, including FDA, EMA, Health Canada, and MHRA authorization timelines, generic availability, and prescribing frameworks.
Evidence-based guide to ezetimibe (Zetia) storage conditions, chemical stability, shelf life, and what to do if tablets are exposed to heat, light, or humidity.
Clinical guide to using ezetimibe (Zetia) in transplant recipients, people living with HIV, patients with chronic kidney disease, and other special populations. Evidence-based dosing, drug interactions, and safety data.
Evidence-based monitoring guide for ezetimibe (Zetia) in children under 12, covering lipid panels, liver function, growth surveillance, and safety benchmarks from AAP and NHLBI guidelines.
A physician-level review of ezetimibe (Zetia) pharmacogenomics, covering NPC1L1 polymorphisms, ABCG5/ABCG8 variants, UGT1A metabolism, and how genetic variability influences LDL-C lowering and cardiovascular outcomes.
Detailed pharmacokinetic profile of ezetimibe (Zetia), covering absorption, glucuronidation metabolism, enterohepatic recirculation, distribution, and elimination, with evidence sourced from the FDA label and clinical pharmacology literature.
A complete guide to obtaining a Zetia (ezetimibe) prescription in Alabama, including telehealth options, required labs, pharmacy access, prior authorization, and insurance coverage details.
A complete guide to obtaining a Zetia (ezetimibe) prescription in Alaska, including telehealth options, lab requirements, pharmacy access, prior authorization, and coverage details for AK residents.
A complete guide to obtaining a Zetia (ezetimibe) prescription in Kansas, including telehealth options, lab requirements, pharmacy access, prior authorization tips, and insurance coverage details.
A complete guide to obtaining a Zetia (ezetimibe) prescription in Kentucky, including telehealth options, required labs, pharmacy access, prior authorization, and cost-saving strategies.
A complete guide to obtaining a Zetia (ezetimibe) prescription in Maine, including telehealth options, pharmacy access, prior authorization, and what labs you need before starting.
A complete guide to getting a Zetia (ezetimibe) prescription in Tennessee, including telehealth options, pharmacy access, prior authorization, and what labs your doctor needs first.
A complete guide to getting a Zetia (ezetimibe) prescription in Texas, including telehealth options, required labs, prior authorization, pharmacy choices, and what to expect from treatment.
A complete guide to getting a Zetia (ezetimibe) prescription in Utah, including telehealth options, lab requirements, prior authorization, and pharmacy access.
A complete guide to obtaining a Zetia (ezetimibe) prescription in Vermont, including telehealth options, lab requirements, pharmacy choices, prior authorization, and dosing details backed by clinical trial data.
A complete guide to getting a Zetia (ezetimibe) prescription in Wyoming, including telehealth options, lab requirements, prior authorization, and pharmacy access.
Evidence-based guide to safely stopping ezetimibe (Zetia), including lipid rebound risks, monitoring timelines, and when discontinuation is clinically appropriate.
Yes, ezetimibe has a favorable safety profile since 2002, with rare liver and muscle risks monitored by the FDA. No black box warnings or withdrawals.
Evidence-based protocols for switching between ezetimibe (Zetia) and other lipid-lowering drugs, including statins, PCSK9 inhibitors, and bempedoic acid. Covers timing, dose adjustments, and monitoring.
How to monitor adolescents ages 12, 17 taking ezetimibe (Zetia) for hyperlipidemia: lipid panels, liver enzymes, growth velocity, mental health screening, and follow-up schedules backed by clinical trial data and current guidelines.
Compare the cost of generic ezetimibe to statins, PCSK9 inhibitors, bempedoic acid, and inclisiran. Includes trial evidence, mechanism of action, and practical prescribing guidance.
Ezetimibe (Zetia) dosing in adolescents ages 12-17, including FDA-approved indications, combination statin therapy, monitoring protocols, and growth considerations for pediatric hyperlipidemia.
Evidence-based guide to ezetimibe (Zetia) dosing in patients with hepatic impairment, including pharmacokinetic data, FDA labeling, clinical recommendations, and monitoring strategies.
A clinical deep-dive into ezetimibe's manufacturing timeline, FDA supply chain events, generic entry, and shortage history from 2002 to present.
Evidence-based missed-dose protocol for ezetimibe (Zetia). Learn when to take a late dose, when to skip, and how missed doses affect your cholesterol control.
A complete clinical guide to ezetimibe monitoring for adults aged 30 to 49, covering lipid panels, liver enzymes, drug interactions, and when to adjust therapy. prepared by the HealthRX.com Editorial Team.
A review of ezetimibe (Zetia) real-world evidence from registries and observational cohorts, set against IMPROVE-IT trial evidence, with an honest account of which specific numbers can and cannot be verified from primary literature.
A guide to ezetimibe (Zetia) safety in adults aged 30, 49, covering liver effects, muscle risk, drug interactions, contraindications, and evidence from IMPROVE-IT and current ACC/AHA guidelines.
A guide to ezetimibe (Zetia) safety in young adults ages 18-29, covering trial evidence, dosing, side effects, fertility considerations, and when to start therapy.
A guide to ezetimibe safety in adolescents ages 12 to 17, covering trial evidence, dosing, growth monitoring, drug interactions, and prescribing guidelines for pediatric hyperlipidemia.
Evidence-based safety profile of ezetimibe (Zetia) in geriatric patients 65+, covering IMPROVE-IT subgroup data, drug interactions, renal considerations, and deprescribing guidance.
A guide to ezetimibe (Zetia) safety for adults aged 50 to 64, covering trial data, drug interactions, muscle and liver risks, hormonal considerations, and practical monitoring guidance.
A clinical history of ezetimibe (Zetia), from its discovery as the first selective cholesterol absorption inhibitor through FDA approval, the IMPROVE-IT landmark trial, and its role in modern lipid-lowering therapy.
Complete dosing guide for ezetimibe (Zetia) in adults aged 30-49, including standard dose, combination therapy adjustments, IMPROVE-IT trial data, and ACC/AHA guideline recommendations.
Find out how much Zetia (ezetimibe) costs in Arizona in 2026, which insurance plans and AHCCCS programs cover it, whether compounded ezetimibe is legal, and how to pay as little as $0 per month.
Find out exactly what ezetimibe (Zetia) costs in California in 2026, which insurance plans and Medi-Cal cover it, whether compounded ezetimibe is legal, and the cheapest ways to pay.
Find out exactly how much Zetia (ezetimibe) costs in Connecticut in 2026, which insurance plans cover it, whether CT Medicaid pays for it, and how to get it for as little as $0/month via a licensed compounding pharmacy.
A complete guide to ezetimibe (Zetia) pricing in Florida for 2026, covering cash-pay rates, Florida Medicaid rules, insurance tiers, GoodRx discounts, and whether compounded ezetimibe is a legal option.
Complete 2026 guide to ezetimibe (Zetia) cost in Massachusetts, including cash prices, MassHealth Medicaid coverage, GoodRx options, manufacturer savings cards, compounded ezetimibe legality, and telehealth access.
Current Zetia (ezetimibe) prices in Minnesota for 2026, including cash-pay, Medicaid, insurance, compounding, and telehealth options. Reviewed by HealthRX.com physicians.
Current ezetimibe prices in Nebraska for 2026, including generic cash-pay costs, Nebraska Medicaid coverage status, compounded ezetimibe via 503A pharmacies, GoodRx discounts, and telehealth prescribing rules.
Find out what Zetia (ezetimibe) costs in Nevada in 2026, how Nevada Medicaid handles coverage, which insurance plans pay for it, and how to get it for as little as $15 per month.
The real cost of Zetia (ezetimibe) in New Hampshire in 2026, including $15/month cash price, NH Medicaid non-coverage, generic options, 503A compounding rules, and telehealth access.
Showing the first 60 matches. Use search or filters to narrow the library.